AbbVie Reports Third-Quarter 2025 Financial Results
PR Newswire —
Reports Third-Quarter Diluted EPS of $0.10 on a GAAP Basis, a Decrease of 88.6 Percent; Adjusted Diluted EPS of $1.86, a Decrease of 38.0 Percent; These Results Include an Unfavorable Impact of $1.50 Per Share Related to Acquired IPR&D and Milestones Expense Delivers Third-Quarter Net...
 
       
             
             
             
             
             
             
             
             
             
             
            